Petco Health and Wellness Company, Inc.

NASDAQ:WOOF

2.775 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 1,552.131,511.4371,523.7551,529.141,674.4761,494.1661,530.7341,555.9081,577.9591,501.221,480.7971,475.9911,514.3571,443.2641,434.5341,414.9941,337.7131,259.9971,208.9711,113.5211,148.6561,093.0691,096.3951,096.395
Cost of Revenue 962.87935.68943.03950.481,068.128944.165937.73951.426950.68903.543886.32868.317878.851848.555835.124818.009768.448718.559679.218647.239650.758620.695628.271628.271
Gross Profit 589.26575.757580.725578.66606.348550.001593.004604.482627.279597.677594.477607.674635.506594.709599.41596.985569.265541.438529.753466.282497.898472.374468.124468.124
Gross Profit Ratio 0.380.3810.3810.3780.3620.3680.3870.3890.3980.3980.4010.4120.420.4120.4180.4220.4260.430.4380.4190.4330.4320.4270.427
Reseach & Development Expenses 000000000000000000000000
General & Administrative Expenses 000000000000000000001.4428.301421.177421.177
Selling & Marketing Expenses 000000000000000000003019.923.923.9
SG&A 571.872571.78578.257595.442606.182559.611568.967576.865549.719549.622544.472557.735552.601532.76525.942549.236502.29495.401464.706449.917437.565448.201445.077445.077
Other Expenses 000001,222.52400000000000000190.30.250.25
Operating Expenses 571.872571.78578.257595.442606.182559.611568.967576.865549.719549.622544.472557.735552.601532.76525.942549.236502.29495.401464.706449.917437.765448.613445.107445.107
Operating Income 17.3883.9772.468-16.7820.166-1,232.13424.03727.61777.5648.05550.00549.93982.90561.94973.46847.74966.97546.03765.04716.36541.13323.87322.79722.797
Operating Income Ratio 0.0110.0030.002-0.0110-0.8250.0160.0180.0490.0320.0340.0340.0550.0430.0510.0340.050.0370.0540.0150.0360.0220.0210.021
Total Other Income Expenses Net -33.833-25.986-36.133-39.064-39.332-35.479-35.239-33.647-35.435-26.601-31.942-19.3-49.3211.02225.969-41.346-67.175-53.746-54.394-60.624-60.662-63.231-64.232-64.232
Income Before Tax -16.445-22.009-33.665-55.846-39.166-1,267.613-11.202-6.0342.12521.45418.06330.63933.58462.97199.4376.403-0.2-7.70910.653-44.259-19.529-39.358-41.435-41.435
Income Before Tax Ratio -0.011-0.015-0.022-0.037-0.023-0.848-0.007-0.0040.0270.0140.0120.0210.0220.0440.0690.005-0-0.0060.009-0.04-0.017-0.036-0.038-0.038
Income Tax Expense 2.504-5.336-4.651-4.477-10.435-22.9026.732-1.00814.5484.1616.638109.68914.09527.0112.67910.2-7.944.958-10.555-7.3958.4479.9089.908
Net Income -13.837-16.673-24.823-46.483-22.575-1,241.137-14.606-1.89232.73219.9213.45624.69328.99452.75275.1117.56-6.1593.4037.441-31.168-7.171-28.219-30.242-30.242
Net Income Ratio -0.009-0.011-0.016-0.03-0.013-0.831-0.01-0.0010.0210.0130.0090.0170.0190.0370.0520.005-0.0050.0030.006-0.028-0.006-0.026-0.028-0.028
EPS -0.05-0.06-0.091-0.17-0.084-4.63-0.055-0.010.120.070.0510.0930.110.20.280.03-0.0290.0130.025-0.11-0.024-0.019-0.021-0.021
EPS Diluted -0.05-0.06-0.091-0.17-0.084-4.63-0.055-0.010.120.070.050.090.110.20.280.03-0.0290.0130.025-0.11-0.024-0.019-0.021-0.021
EBITDA 68.0954.08652.18631.68753.843-1,179.98274.95580.427125.23697.68488.48697.2499.271124.532159.88168.53995.69689.009107.61760.11685.21167.85965.60465.604
EBITDA Ratio 0.0440.0360.0340.0210.032-0.790.0490.0520.0790.0650.060.0660.0660.0860.1110.0480.0720.0710.0890.0540.0740.0620.060.06